Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of ZEST-LATE (Evaluation of the Long-term Safety After Zotarolimus-Eluting Stent,
Sirolimus-Eluting Stent, or PacliTaxel-Eluting Stent Implantation for Coronary Lesions - Late
Coronary Arterial Thrombotic Events) trial is to assess the relationship between long-term
clopidogrel use beyond 1 year and long-term rates of death or MI after DES implantation and
to estimate the duration of dual antiplatelet therapy for preventing the late thrombotic
events.